These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 31026734)
1. Stigma and drug use settings as correlates of self-reported, non-fatal overdose among people who use drugs in Baltimore, Maryland. Latkin CA; Gicquelais RE; Clyde C; Dayton L; Davey-Rothwell M; German D; Falade-Nwulia S; Saleem H; Fingerhood M; Tobin K Int J Drug Policy; 2019 Jun; 68():86-92. PubMed ID: 31026734 [TBL] [Abstract][Full Text] [Related]
2. The relationship between drug use settings, roles in the drug economy, and witnessing a drug overdose in Baltimore, Maryland. Latkin CA; Edwards C; Davey-Rothwell MA; Yang C; Tobin KE Subst Abus; 2018; 39(3):384-389. PubMed ID: 29432084 [TBL] [Abstract][Full Text] [Related]
3. Fatal overdose prevention and experience with naloxone: A cross-sectional study from a community-based cohort of people who inject drugs in Baltimore, Maryland. Buresh M; Gicquelais RE; Astemborski J; Kirk GD; Mehta SH; Genberg BL PLoS One; 2020; 15(3):e0230127. PubMed ID: 32160244 [TBL] [Abstract][Full Text] [Related]
4. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Park JN; Weir BW; Allen ST; Chaulk P; Sherman SG Harm Reduct J; 2018 Jul; 15(1):34. PubMed ID: 29976195 [TBL] [Abstract][Full Text] [Related]
5. The relationship between felt stigma and non-fatal overdose among rural people who use drugs. Sibley AL; Klein E; Cooper HLF; Livingston MD; Baker R; Walters SM; Gicquelais RE; Ruderman SA; Friedmann PD; Jenkins WD; Go VF; Miller WC; Westergaard RP; Crane HM Harm Reduct J; 2024 Apr; 21(1):77. PubMed ID: 38582851 [TBL] [Abstract][Full Text] [Related]
6. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301 [TBL] [Abstract][Full Text] [Related]
7. Trends in overdose experiences and prevention behaviors among people who use opioids in Baltimore, MD, 2017-2019. Dayton L; Mazhnaya A; Schneider KE; Kong X; Winiker A; Davey-Rothwell M; Tobin KE; Latkin CA Drug Alcohol Depend; 2021 Apr; 221():108650. PubMed ID: 33684772 [TBL] [Abstract][Full Text] [Related]
8. Knowledge of Good Samaritan Laws and Beliefs About Arrests Among Persons Who Inject Drugs a Year After Policy Change in Baltimore, Maryland. Schneider KE; Park JN; Allen ST; Weir BW; Sherman SG Public Health Rep; 2020; 135(3):393-400. PubMed ID: 32264789 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study. Bazazi AR; Zelenev A; Fu JJ; Yee I; Kamarulzaman A; Altice FL Int J Drug Policy; 2015 Jul; 26(7):675-81. PubMed ID: 25532449 [TBL] [Abstract][Full Text] [Related]
10. Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention. Wagner KD; Liu L; Davidson PJ; Cuevas-Mota J; Armenta RF; Garfein RS Drug Alcohol Depend; 2015 Aug; 153():215-20. PubMed ID: 26091751 [TBL] [Abstract][Full Text] [Related]
11. High Prevalence of Self-Reported Exposure to Adulterated Drugs Among People Who Experienced an Opioid Overdose in Canada: A Cohort Study. Prangnell A; Fairgrieve C; Nosova E; DeBeck K; Milloy MJ; Hayashi K Subst Use Misuse; 2019; 54(6):980-985. PubMed ID: 30663484 [TBL] [Abstract][Full Text] [Related]
12. Perceived Causes of Personal versus Witnessed Overdoses among People who Inject Opioids. Behar E; Chang JS; Countess K; Matheson T; Santos GM; Coffin P Subst Use Misuse; 2019; 54(12):1929-1937. PubMed ID: 31070106 [No Abstract] [Full Text] [Related]
13. Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: A latent class analysis. Schneider KE; Park JN; Allen ST; Weir BW; Sherman SG Drug Alcohol Depend; 2019 Aug; 201():71-77. PubMed ID: 31195347 [TBL] [Abstract][Full Text] [Related]
14. Fatal and non-fatal overdose among opiate users in South Wales: A qualitative study of peer responses. Holloway K; Hills R; May T Int J Drug Policy; 2018 Jun; 56():56-63. PubMed ID: 29605706 [TBL] [Abstract][Full Text] [Related]
15. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada. Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241 [TBL] [Abstract][Full Text] [Related]
16. More than just availability: Who has access and who administers take-home naloxone in Baltimore, MD. Dayton L; Gicquelais RE; Tobin K; Davey-Rothwell M; Falade-Nwulia O; Kong X; Fingerhood M; Jones AA; Latkin C PLoS One; 2019; 14(11):e0224686. PubMed ID: 31697736 [TBL] [Abstract][Full Text] [Related]
17. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence. Rouhani S; Park JN; Morales KB; Green TC; Sherman SG Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942 [TBL] [Abstract][Full Text] [Related]
18. Fentanyl and Drug Overdose: Perceptions of Fentanyl Risk, Overdose Risk Behaviors, and Opportunities for Intervention among People who use Opioids in Baltimore, USA. Latkin CA; Dayton L; Davey-Rothwell MA; Tobin KE Subst Use Misuse; 2019; 54(6):998-1006. PubMed ID: 30767590 [TBL] [Abstract][Full Text] [Related]
19. Stigma, and factors associated with experiencing stigma, while visiting health-care services among samples of people who use illegal drugs in Australia. Sutherland R; King C; Karlsson A; Treloar C; Broady T; Chandrasena U; Salom C; Dietze P; Peacock A Drug Alcohol Rev; 2024 Jul; 43(5):1264-1279. PubMed ID: 38644679 [TBL] [Abstract][Full Text] [Related]
20. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants. Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]